New oral GLP-1 drugs could offer more options for weight loss
GLP-1 injections require refrigeration and needles. Pills wouldn’t
An Eli Lilly employee collects product during the manufacturing of orforglipron, an investigational oral GLP-1 drug, at a Lilly facility. New clinical trials show that orforglipron and another oral drug help people with obesity lose weight.
Eli Lilly